Hematology-Oncology Associates of CNY

East Syracuse, New York 13057

2 studies enrolling now · 7 studies all time

What they study most

Aging, Breast Cancer, Breast Tumor, Cancer of the Breast, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-small-Cell Lung, Cognition, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Melanoma, Metastases, Metastatic Breast Cancer

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed
• Cognition in the Study of Tamoxifen and Raloxifene — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• Non-small Cell Lung Cancer Registry — Completed